NCT03048318|CompletedPhase 4DMC
Loading search results
Sponsor study identifier
interventional
85
0 countries
N/A
Study Start
October 1, 2015
Actual (reported)Primary Completion
April 30, 2017
Actual (reported)Study Completion
April 30, 2017
Actual (reported)Arterial flushing is a standard recommendation in deceased donor liver transplantation but not in living donor liver transplantation due to the risk of arterial intimal injury and short cold ischaemia time. There is recent evidence on benefit of retrograde arterial perfusion using hepatic venous occlusion and its benefits on post transplant cholestasis. However there is no data on antegrade arterial flushing.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 30, 2017
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
October 1, 2015
Actual (reported)January 31, 2017
Actual (reported)February 9, 2017
Actual (reported)April 30, 2017
Actual (reported)April 30, 2017
Actual (reported)Effects on biliary complications
Occurence of biliary complication
Three months
Hospital stay
1 month
Morbidity
1 month
Effect on graft function
3 months
Back table flush of portal vein and graft artery
Back table flush of portal vein only
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Pamecha V, Sandhyav R, Sinha PK, Bharathy KGS, Sasturkar S. Antegrade Arterial and Portal Flushing Versus Portal Flushing Only for Right Lobe Live Donor Liver Transplantation-A Randomized Control Trial. Transplantation. 2018 Apr;102(4):e155-e162. doi: 10.1097/TP.0000000000002088.
Rommel Sandhyav, MS
Institute of Liver and Biliary Sciences, India
Viniyendra Pamecha, MS, FRSS, FEBS
Professor
Senthil Kumar, MS, FRCS
Additional Professor
Shridhar Sasturkar, MS, MCh
Assistant Professor
85 participants (actual enrollment reported by the registry).
First Submitted
January 31, 2017
First Posted
February 9, 2017
Study Start
October 1, 2015
Actual (reported)A Kidney Transplant Study to Look at the Effects of Taking Fixed Doses of CellCept Versus Taking Doses of CellCept Based on the Concentration of CellCept in the Blood When Taking Full or Reduced Dose Calcineurin Inhibitors
Contact the study team to confirm eligibility.
Piyush Kumar Sinha, MS, MCh
Assistant Professor
Primary Completion
April 30, 2017
Actual (reported)Study Completion
April 30, 2017
Actual (reported)Last Updated
June 29, 2017
Record last verified: 2017-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: